drugset / Trial / NCT01136655

A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy

NCT01136655

Phase 2 Completed 54 enrolled AstraZeneca
RandomizedCrossoverQuadruple-blindTreatment

Summary

This purpose of the study is to investigate the bronchodilating effects of 3 different dosages of formoterol given in combination with budesonide as Symbicort pMDI.

Timeline

Start
2010-09
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified 2.25 ug Inhaled
Subject Formoterol Other / unclassified 4.5 ug Inhaled
Subject Formoterol Other / unclassified 9 ug Inhaled
Subject Formoterol Other / unclassified 12 ug Inhaled
Background Budesonide Small molecule 40 ug Inhaled

Indications